

Biomerieux – Group report and key figures
A report presented through summary slides of group's operations
Detailed history of financial performances between 2023 and 2024
An overview of the group's major business strategies
A medium-term outlook for opportunities and threats
650 €
WHAT IS THE GROUPS' FINANCIAL SITUATION ?
The financial indicators presented in this report include: consolidated revenue, consolidated EBIT and EBIT ratio, consolidated net profit and net profit rate, R&D expenditure and ratio, sales by segment and by region, profitability, liquidity and solvency ratios, free cash flow and capital expenditure.
WHAT ARE THE GROUP'S STRATEGIC PRIORITIES ?
Extend leadership positions in key markets through external growth
Sustain expansive innovation footprint and investment
Enhance service integration to develop a comprehensive offering
WHAT ARE THE GROUP'S STRENGTHS AND WEAKNESSES ?
Through a SWOT analysis, this report also provides an overview of the group's strengths (solid financial position facilitates investments to grow production footprint and engage in M&A activities, etc.) and weaknesses (smaller in size compared to major European and American rivals, etc.).
Detailed plan
Presentation
Segments
SWOT

ACCESS THE REPORT


